IINDABA EZINKULU ZE-CHUANGKUN BIOTECH KWIMAKEKETHI YAPHEZULU I-SHANGHAI CHUANGKUN I-BIOTECH TB/IKHITHI YOKUFUMANA I-NTM-DNA(LYOPHILIZED) YAMNIKELWE YI-THAILAND FDA!

Ngomhla woku-1, uFebruray, eShanghai Chuangkun Biotechnology Co., Ltd. ifumene isatifikethi sesibini sobhaliso saseThailand FDA se-TB/NTM-DNA yokufumanisa ikiti, enyathelwe luhlobo lwe-15 lwekhithi yokufumanisa i-PCR kwinyanga enye edlulileyo.eyabhengeza ukuba iimveliso ze-Chuangkun Biotech zigunyaziswe yi-Thailand FDA, iphucula iimveliso eziziphuhlisileyo, kwaye ikwabonelela ngenkxaso eyomeleleyo yeChuangkun Biotech ukwandisa ngakumbi imarike yamazwe ngamazwe.

Kuqikelelwa ukuba i-10.6 yezigidi zabantu kwihlabathi jikelele bagula ngenxa ye-TB epapashwe yi-WHO ngo-2021. Isantya esonyuka nge-4.5% ngaphezu konyaka ka-2020. Ngeli xesha i-1.6 yezigidi zabantu babulawa sisifo sephepha kulo nyaka uphelileyo (kuquka i-6.7% babephakathi kwabantu abaphila ne-HIV) .Ngokwendawo, uninzi lwezehlo ze-TB ngo-2021 zazikwimimandla ye-WHO ye-South-East Asia (45%), i-Afrika (23%) kunye ne-Western Pacific (18%), kunye nezabelo ezincinci kwi-Eastern Mediterranean (8.1%), eMelika. (2.9%) kunye neYurophu (2.2%).Ukuthathela ingqalelo ubhubhani we-COVID-19, uthintelo kunye nolawulo lwesifo sephepha kuba nzima ngakumbi kwiSicwangciso sokuPheliswa kweSifo sePhepha se-WHO.

I-TB/NTM-DNA yokufumanisa ikiti ye-CHUANGKUN I-Biotech iyilwe yinkqubo ye-lyophilization Inkqubo iya kusombulula ukungahambi kakuhle kwexesha elide lothutho kwikhithi yokufumanisa i-PCR yemveli, ikwazisa ukuchaneka okugqwesileyo kunye neziphumo eziphezulu eziphezulu ngaphezulu kokulula kokusetyenziswa.

I-Shanghai Chuangkun Biotechnology Co., Ltd. ifumene isatifikethi sobhaliso sesibini sase-Thailand FDA se-TB/NTM-DNA yokubona ikhithi, ebonisa ukuvunywa yi-Thailand FDA.I-Chuangkun Biotech iya kubandakanyeka ekuthinteleni isifo sephepha kunye nokulawula ngamandla.